Abstract: To explore the prognosis of epithelial ovarian cancer patients with multiple recurrences (≥2 times) who underwent three times or more cytoreductive surgeries, and to analyze the factors associated with prognosis. The clinicopathological data and follow-up data of 23 patients with ovarian cancer admitted to the Obstetrics and Gynecology Hospital of Fudan University from January 1, 2015 to January 30, 2022 with three times or more cytoreductive surgeries were collected. The degree of surgical resection, site of recurrence and metastasis, postoperative complications, and prognosis were retrospectively analyzed. The univariate Cox proportional hazards model was performed to identify the variables associated with survival. (1) The median age of 23 patients with multiple recurrent ovarian cancer was 48 years old (44-55 years). Among them, 18 cases underwent tertiary cytoreductive surgery (TCS), 2 cases underwent quaternary cytoreductive surgery, 2 cases underwent quinary cytoreductive surgery, and 1 case underwent senary cytoreductive surgery. Among the 23 patients with multiple recurrent ovarian cancer, 21 cases (91%, 21/23) had serous carcinoma, 16 cases (70%, 16/23) had advanced stage (stage Ⅲ-Ⅳ), and 19 cases (83%, 19/23) had high differentiation. (2) Based on the premise that satisfactory cytoreduction was achieved by primary debulking surgery (PDS) and no visible residual disease (R0) was achieved by secondary cytoreductive surgery (SCS), the maximum diameter of the recurrent tumors was up to 10.0 cm and 62% (20/32) of patients with multiple metastatic sites. The R0 rate for three times or more cytoreductive surgeries (32 times in total) reached 88% (28/32), with a postoperative complication rate of 47% (15/32), and only 3% (1/32) for grade Ⅲ or above. During a median follow-up time of 31.1 months (20.6-43.9 months) after TCS, 20 patients (87%, 20/23) recurred after TCS, and 8 patients (35%, 8/23) eventually died of ovarian cancer. Among them, the three-year postoperative survival rate of 22 patients with R0 was 57.6%, and the patient with residual lesions ≥1 cm died at 9.2 months after TCS. (3) In univariate analysis, ages, the time interval between PDS and SCS >32 months, the interval between SCS and TCS >16 months, and no metastatic peritoneal carcinoma were associated with longer progression free survival after TCS (all <0.05); while treatment-free interval (TFI) >10 months after SCS, the interval between SCS and TCS >16 months, no ascites and platinum-sensitive status were associated with disease-specific survival after TCS (all <0.05). It is feasible to perform three times or more cytoreductive surgeries in patients with multiple recurrent ovarian cancer who are expected to achieve R0 and have manageable complications. However, the pros and cons of surgery need to be carefully evaluated for the patients whose ascites are massive and whose previous cytoreduction does not achieve R0. A prolonged TFI and previously longer surgical interval might get potential survival benefits.

Characteristics of recurrent endometriosis and second surgery.

The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review

Risk Factors for Coexisting Deep Endometriosis for Patients with Recurrent Ovarian Endometrioma.

Repetitive surgery for recurrent symptomatic endometriosis: What to do?

Long-term risk of repeated surgeries in women managed for endometriosis: a 1,092 patient-series

Experience of Ipsilateral Laparoseopic Reoperations in Urology

Comparison Of Subsequent Pregnancy Outcomes After Surgery For Adnexal Masses Performed In The First And Second Trimester Of Pregnancy

Upregulation of H-Tert and Ki-67 in Ectopic Endometrium is Associated with Recurrence of Endometriosis

Status and related factors of postoperative recurrence of ovarian endometriosis: a cross-sectional study of 874 cases

Recurrence, Reoperation, Pregnancy Rates, and Risk Factors for Recurrence after Ovarian Endometrioma Surgery: Long-Term Follow-Up of 756 Women

Recurrence of endometriosis after hysterectomy

Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women

The influence of uterine surgery on the ovarian function of women during the reproduc-tive period

Rates of Subsequent Endometriosis-Related Surgeries Following an Initial Laparoscopy or Hysterectomy: A Longitudinal Analysis of Commercially Insured Endometriosis Patient in the United States

[Analysis of prognosis and associated factors in multiple recurrent epithelial ovarian cancer with three times or more cytoreductive surgeries].

Factors that Increase the Likelihood of Ovarian Endometriosis Relapsing after Surgical Excision: A Systematic Review and Meta-Analysis

Surgical treatment of deep endometriosis and risk of recurrence

Recurrence rate of endometriomas following a laparoscopic cystectomy

Patterns of and Risk Factors for Recurrence in Women with Ovarian Endometriomas

The results of fertility conservative surgery for recurrent borderline ovarian tumors

Characteristics and Related Factors of Recurrent Epithelial Ovarian Carcinoma:61 Cases Report